Tazopen Injection

Tazopen 2 gm + 250 mg/vial Injection সম্পর্কে

বাংলাদেশে Tazopen 2 gm + 250 mg/vial Injection ইনজেকশন হিসেবে পাওয়া যায়; এতে Piperacillin + Tazobactam আছে (২ gm + ২৫০ mg/vial)। Tazopen-এর সাথে Piperacillin + Tazobactam-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। এটি তৈরি করে Renata PLC। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।

Piperacillin + Tazobactam-এর ৮টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Brodactam (2 gm+0.25 gm)/vial IV Infusion-এর, প্রতি ইউনিট ৳ ৬০২.০০।

Tazopen 2 gm + 250 mg/vial Injection কী?

Tazopen is a combination antibiotic injection. Piperacillin belongs to the penicillin group and works by interfering with the building of the bacterial cell wall, which stops bacteria from multiplying. Tazobactam is a beta-lactamase inhibitor: it blocks enzymes that some bacteria produce to destroy penicillins, so the piperacillin can act against bacteria that would otherwise resist it. Together they cover many gram-positive and gram-negative bacteria, including some that produce these enzymes. Tazopen is supplied as an injection containing 2 gm + 250 mg/vial and is given in hospital settings for moderate to severe infections caused by susceptible bacteria.

Tazopen-এর ব্যবহার

Tazopen is used to treat moderate to severe infections caused by bacteria that are sensitive to the combination. These include certain infections inside the abdomen, as well as other infections for which this type of antibiotic is considered appropriate. Because it is a prescription hospital medicine, the doctor decides whether it is suitable after assessing the infection and the person's condition. It is not for viral illnesses such as the common cold.

Tazopen কীভাবে ব্যবহার করবেন

Tazopen is given by intravenous infusion, meaning it is delivered through a vein over a period of time, and it is administered by a healthcare professional. The doctor decides the dose, the interval between doses and how long the course should continue, taking into account the type and severity of the infection and the person's kidney function. Do not attempt to use or adjust the injection yourself. Ask the doctor or pharmacist if you have questions about the schedule.

Tazopen-এর পার্শ্বপ্রতিক্রিয়া

Common side effects involve the skin, such as rash and itching, and the stomach and bowel, such as diarrhoea, constipation, nausea, vomiting and abdominal pain. Some people have fever, chills or a reaction at the injection site. Less common effects include allergic reactions, which can be serious, fungal infections such as candidiasis, bowel inflammation, low blood sugar, muscle and joint pain and sleep problems. Tell the doctor or nurse promptly about any new or worsening symptoms.

সতর্কতা ও নিরাপত্তা

Do not receive Tazopen if you have had an allergic reaction to penicillins, cephalosporins or beta-lactamase inhibitors. Serious allergic reactions can occur, and treatment is stopped if one develops. Severe skin reactions have been reported, so a worsening rash should be reported at once. Blood counts and bleeding can be affected during prolonged treatment, and the doctor may arrange monitoring. The medicine crosses the placenta, and there is not enough information to judge its safety in pregnancy; piperacillin passes into breast milk. Tell the doctor if you are pregnant, breastfeeding, have kidney problems or take other medicines.

সাধারণ প্রশ্ন

What does the dosage form and strength of Tazopen mean?

Tazopen is an injection supplied as a vial containing 2 gm of piperacillin and 250 mg of tazobactam. The strength describes how much of each ingredient is in the vial, and the injection is prepared and given by a healthcare professional. The doctor decides how much is needed and how often it is given.

What is Tazopen used for and what kind of medicine is it?

Tazopen is a combination antibiotic injection. It contains piperacillin, a penicillin-type antibiotic, and tazobactam, which blocks enzymes that some bacteria use to resist penicillins. It is used for moderate to severe bacterial infections, such as certain infections inside the abdomen, when the doctor judges it appropriate.

How should Tazopen be taken?

Tazopen is not taken by mouth. It is given by intravenous infusion by a doctor or nurse, usually in a hospital or clinic. The doctor decides the dose, how often it is given and how long the course lasts, based on the infection and the person's health. Never adjust the injection yourself.

Who should ask the doctor before receiving Tazopen?

Tell the doctor if you have ever had an allergic reaction to penicillins, cephalosporins or beta-lactamase inhibitors, or if you have kidney problems. Also mention pregnancy, breastfeeding and any other medicines you take, so the doctor can decide whether Tazopen is suitable for you.

নির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Piperacillin and tazobactam is a combination product consisting of a penicillin-class antibacterial, piperacillin, and a β-lactamase inhibitor, tazobactam, indicated for the treatment of patients with moderate to severe infections caused by susceptible isolates of the designated bacteria in the ... Read morePiperacillin and tazobactam is a combination product consisting of a penicillin-class antibacterial, piperacillin, and a β-lactamase inhibitor, tazobactam, indicated for the treatment of patients with moderate to severe infections caused by susceptible isolates of the designated bacteria in the conditions listed below.

Intra-abdominal Infections: Appendicitis (complicated by rupture or abscess) and peritonitis caused by β-lactamase producing isolates of Escherichia coli or the following members of the Bacteroides fragilis group: B. fragilis, B. ovatus, B. thetaiotaomicron, or B. vulgatus.

Skin and Skin Structure Infections: Uncomplicated and complicated skin and skin structure infections, including Cellulites, cutaneous abscesses and ischemic/diabetic foot infections caused by β-lactamase producing isolates of Staphylococcus aureus.

Female Pelvic Infections: Postpartum endometritis or pelvic inflammatory disease caused by β-lactamase producing isolates of Escherichia coli.

Community-acquired pneumonia: Community-acquired pneumonia (moderate severity only) caused by β lactamase producing isolates of Haemophilus influenzae.

Nosocomial pneumonia: Nosocomial pneumonia (moderate to severe) caused by β-lactamase producing isolates of Staphylococcus aureus and by piperacillin/tazobactam-susceptible Acinetobacter baumanii, Haemophilus influenzae, Klebsiella pneumoniae, and Pseudomonas aeruginosa (Nosocomial pneumonia caused by P. aeruginosa should be treated in combination with an aminoglycoside).

ফার্মাকোলজি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Piperacillin, a broad spectrum, semi-synthetic penicillin active against many gram-positive and gram-negative aerobic and anaerobic bacteria, exerts bactericidal activity by inhibition of both septum and cell wall synthesis. Tazobactam is a potent inhibitor of many beta-lactamases, including the plasmid and chromosomally mediated enzymes that commonly cause resistance to penicillins. Tazobactam enhances and extends the antibiotic spectrum of Piperacillin to include many beta-lactamase-producing bacteria normally resistant to it. Thus, this infusion combines the properties of a broad-spectrum antibiotic and a beta-lactamase inhibitor.

মাত্রা ও সেবনবিধি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Piperacillin and tazobactam should be administered by intravenous infusion over 30 minutes.

Adult Patients: The usual total daily dose of Piperacillin and tazobactam for adults is 3.375 g every six hours totaling 13.5 g (12.0 g piperacillin/1.5 g tazobactam). The usual duration of treatment is from 7 to 10 days.

Nosocomial Pneumonia: Initial presumptive treatment of patients with nosocomial pneumonia should start with piperacillin and tazobactam at a dosage of 4.5 g every six hours plus an aminoglycoside, totaling 18.0 g (16.0 g piperacillin/2.0 g tazobactam). The recommended duration of the treatment for nosocomial pneumonia is 7 to 14 days. Treatment with the aminoglycoside should be continued in patients from whom Pseudomonas aeroginosa is isolated.

Pediatric Patients: For children with appendicitis and/or peritonitis 9 months of age or older, weighing up to 40 kg, and with normal renal function, the recommended piperacillin and tazobactam dosage is 100 mg piperacillin/12.5 mg tazobactam per kilogram of body weight, every 8 hours. For pediatric patients between 2 months and 9 months of age, the recommended dosage based on Pharmacokinetic modeling, is 80 mg piperacillin/10 mg tazobactam per kilogram of body weight, every 8 hours. Pediatric patients weighing over 40 kg and with normal renal function should receive the adult dose. It has not been determined how to adjust piperacillin and tazobactam dosage in pediatric patients with renal impairment.

ঔষধের মিথষ্ক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Aminoglycosides: Piperacillin may inactivate aminoglycosides by converting them to microbiologically inert amides. When aminoglycosides are administered in conjunction with piperacillin to patients with end-stage renal disease requiring hemodialysis, the concentrations of the aminoglycosides (especially tobramycin) may be significantly reduced and should be monitored.

Sequential administration of pipercillin and tazobactam and tobramycin to patients with either normal renal function or mild to moderate renal impairment has been shown to modestly decrease serum concentrations of tobramycin but no dosage adjustment is considered necessary.

Probenecid: Probenecid administered concomitantly with piperacillin and tazobactam prolongs the half-life of piperacillin by 21% and that of tazobactam by 71% because probenecid inhibits tubular renal secretion of both piperacillin and tazobactam. Probenecid should not be co-administered with Pipercillin and tazobactam unless the benefit outweighs the risk.

Anticoagulants: Coagulation parameters should be tested more frequently and monitored regularly during simultaneous administration of high doses of heparin, oral anticoagulants, or other drugs that may affect the blood coagulation system or the thrombocyte function.

Vecuronium: Piperacillin when used concomitantly with vecuronium has been implicated in the prolongation of the neuromuscular blockade of vacuronium, piperacillin and tazobactam could produce the same phenomenon if given along with vecuronium. Due to their similar mechanism of action, it is expected that the neuromuscular blockade produced by any of the non-depolarizing muscle relaxants could be prolonged in the presence of piperacillin.

Methotrexate: Limited data suggests that co-administration of methotrexate and piperacillin may reduce the clearance of methotrexate due to competition for renal secretion. The impact of tazobactam on the elimination of methotrexate has not been evaluated. If concurrent therapy is necessary, serum concentrations of methotrexate as well as the signs and symptoms of methotrexate toxicity should be frequently monitored.

প্রতিনির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Piperacillin and tazobactam is contraindicated in patients with a history of allergic reactions to any of the penicillins, cephalosporins, or β -lactamase inhibitors.

পার্শ্ব প্রতিক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Adverse events primarily involving the skin, including rash, pruritus and Purpura; the gastrointestinal system including diarrhea, Constipation, nausea, vomiting, Dyspepsia and Abdominal Pain; General disorders and administration site conditions including Fever, Injection site reaction (≤1%) and Rigors. (≤1%), Immune hypersensitivity reactions, anaphylactic/anaphylactoid reactions (including shock) (≤1%), Infections-Candidiasis and Pseudomembranous colitis (≤1%), Metabolism and nutrition disorders- Hypoglycemia (≤1%), Musculoskeletal and connective tissue disorders- Myalgia and Arthralgia (≤1%), Psychiatric disorders Insomnia, Vascular disorders- Phlebitis Thrombophlebitis(≤1%), Hypotension(≤1%), Flushing(≤1%), Respiratory, thoracic and mediastinal disorders- Epistaxis (≤1%).

গর্ভাবস্থায় ও স্তন্যদানকালে

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Piperacillin and tazobactam cross the placenta in humans. However, there are insufficient data with piperacillin and/or tazobactam in pregnant women to inform a drug-associated risk for major birth defects and miscarriage. Piperacillin is excreted in human milk; tazobactam concentrations in human milk have not been studied. No information is available on the effects of piperacillin and tazobactam on the breastfed child or on milk production.

সতর্কতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Serious hypersensitivity reactions (anaphylactic/anaphylactoid) reactions have been reported in patients receiving Piperacillin and tazobactam. Discontinue Piperacillin and tazobactam if a reaction occurs.

Piperacillin and tazobactam may cause severe cutaneous adverse reactions, such as Stevens- Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms, and acute generalized exanthematous pustulosis. Discontinue Piperacillin and tazobactam for progressive rashes.

Hematological effects (including bleeding, leukopenia and neutropenia) have occurred. Monitor hematologic tests during prolonged therapy.

Nephrotoxicity in critically ill patients has been observed; the use of Piperacillin and tazobactam was found to be an independent risk factor for renal failure and was associated with delayed recovery of renal function as compared to other beta-lactam antibacterial drugs in a randomized, multicenter, controlled trial in critically ill patients. Based on this study, alternative treatment options should be considered in the critically ill population. If alternative treatment options are inadequate or unavailable, monitor renal function during treatment with Piperacillin and tazobactam.

Clostridium difficile associated diarrhea: Evaluate patients if diarrhea occurs.

মাত্রাধিক্যতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

There have been post marketing reports of overdose with piperacillin/tazobactam. The majority of those events experienced, including nausea, vomiting, and diarrhea, have also been reported with the usual recommended dosages. Patients may experience neuromuscular excitability or convulsions if higher than recommended doses are given intravenously (particularly in the presence of renal failure). Treatment should be supportive and symptomatic according the patient's clinical presentation.

সংরক্ষণ

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

বিকল্প ব্র্যান্ড: Piperacillin + Tazobactam

একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।

Brodactam IV Infusion

(2 gm+0.25 gm)/vial

Piperacillin + Tazobactam

Synovia Pharma PLC.

৳ ৫৮৯.৯৬ ৳ ৬০২.০০ ২% ছাড় প্রতি ইউনিট

Brodactam IV Infusion

(4 gm+0.5 gm)/vial

Piperacillin + Tazobactam

Synovia Pharma PLC.

৳ ৯৮২.৯৪ ৳ ১০০৩.০০ ২% ছাড় প্রতি ইউনিট

ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।